<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38375">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01747122</url>
  </required_header>
  <id_info>
    <org_study_id>2012/R/SU/01 - LIVER 2 Trial</org_study_id>
    <nct_id>NCT01747122</nct_id>
  </id_info>
  <brief_title>The Effects of Local Infiltration Versus Epidural Following Liver Resection 2</brief_title>
  <acronym>LIVER 2</acronym>
  <official_title>A Randomised Trial of Peri-operative Nerve Block and Continuous Infusion of Local Anaesthetic Via Wound Catheter Versus Epidural in Patients Undergoing Open Liver Resection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Lothian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <authority>Scotland: Academic and Clinical Central Office for Research and Development (ACCORD)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to compare epidurals versus wound catheters for effects on pain
      relief and recovery following open liver surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Measurement made on day of discharge which is expected to be on average bewteen 5 and 10 days after surgery.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of days (to nearest half day) patients stay in hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>Performed daily at 0900 hours. On the day of surgery pain scores will be performed at 2, 6 and 12 hours post surgery.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual analogue scores of pain experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Molecular response to surgery</measure>
    <time_frame>Days 0, 1 and 3</time_frame>
    <safety_issue>No</safety_issue>
    <description>HMGB1, RAGE and cytokines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Venous Pressure</measure>
    <time_frame>During liver transection</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean Central Venous Pressure during liver transection will be quantified and compared between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Blood Loss</measure>
    <time_frame>Intra-operative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative field asessment</measure>
    <time_frame>During liver transection</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pringle time</measure>
    <time_frame>Intra-operative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of Life (EQ-5D)</measure>
    <time_frame>Pre-operative, 2 weeks post-operative, 4-6 weeks post-operative</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>Day of surgery and postoperative days 1-7</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>IV Fluid volume</measure>
    <time_frame>Day of Surgery and postoperative days 1-7</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Complications</measure>
    <time_frame>day of surgery and post-operative days 1-30</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Post-operative blood tests (FBC, U&amp;E, LFTs, coag)</measure>
    <time_frame>Post-operative days 1-7</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Open Liver Resection</condition>
  <arm_group>
    <arm_group_label>Wound catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wound catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard epidural, pre-operative insertion, to be run for 48 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wound catheter</intervention_name>
    <description>Wound catheter, placed at end of procedure, prior to closure. To be kept in for 48 hours.</description>
    <arm_group_label>Wound catheter</arm_group_label>
    <other_name>On-Q Painbuster</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural</intervention_name>
    <arm_group_label>Epidural</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing open hepatic resection for benign or malignant conditions.

        Exclusion Criteria:

          -  Patients with contraindication to either epidural or wound catheter techniques.

          -  Inability to give written, informed consent.

          -  Jaundice (Bilirubin &gt; 100 Î¼mol/L)

          -  Liver resection combined with secondary surgical procedure.

          -  Age &lt; 18 years

          -  Pregnant women

          -  patients on long term opiates for chronic pain
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Hughes, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Edinburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael J Hughes, MBChB</last_name>
    <phone>0131 242 3631</phone>
    <phone_ext>23631</phone_ext>
    <email>michaelh@doctors.net.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <state>Lothian</state>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael J Hughes, MBChB</last_name>
      <phone>0131 242 3631</phone>
      <phone_ext>23631</phone_ext>
      <email>michaelh@doctors.net.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Revie EJ, McKeown DW, Wilson JA, Garden OJ, Wigmore SJ. Randomized clinical trial of local infiltration plus patient-controlled opiate analgesia vs. epidural analgesia following liver resection surgery. HPB (Oxford). 2012 Sep;14(9):611-8. doi: 10.1111/j.1477-2574.2012.00490.x. Epub 2012 Jun 10.</citation>
    <PMID>22882198</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>November 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidurals</keyword>
  <keyword>wound catheters</keyword>
  <keyword>liver resection</keyword>
  <keyword>liver surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
